Skip to main content
. 2024 May 5;25(9):5037. doi: 10.3390/ijms25095037

Table 1.

Therapeutic potential of TLRs.

Approach Examples Diseases Reference
TLR Agonists Poly-ICLC, MEDI9197, QbG10, Resiquimod, Imiquimod Cancer, infectious diseases, allergies, HPV [10,11,12]
TLR Antagonists TAC5, MHV370 Autoimmune diseases (psoriasis, SLE), inflammatory conditions [13,14]
Vaccine Adjuvants Monophosphoryl Lipid A (MPL), CpG-1018, Resiquimod, Imiquimod Infectious diseases (HBV, HCV, HIV, SARS-CoV-2, influenza, HPV) [10,11,12]